These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 37116016

  • 1. Proband and the Brother.
    B S, Kotha JP.
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116016
    [Abstract] [Full Text] [Related]

  • 2.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Wallace SE, Wilcox WR.
    ; 1993 Jan. PubMed ID: 20301335
    [Abstract] [Full Text] [Related]

  • 3. Camurati-Engelmann disease (progressive diaphyseal dysplasia) in a Moroccan family.
    Simsek S, Janssens K, Kwee ML, Van Hul W, Veenstra J, Netelenbos JC.
    Osteoporos Int; 2005 Sep; 16(9):1167-70. PubMed ID: 15959620
    [Abstract] [Full Text] [Related]

  • 4. Orthopedic Manifestations of Type I Camurati-Engelmann Disease.
    Yuldashev AJ, Shin CH, Kim YS, Jang WY, Park MS, Chae JH, Yoo WJ, Choi IH, Kim OH, Cho TJ.
    Clin Orthop Surg; 2017 Mar; 9(1):109-115. PubMed ID: 28261436
    [Abstract] [Full Text] [Related]

  • 5. Significant Improvement After Surgery for a Symptomatic Osteoblastoma in a Patient with Camurati-Engelmann Disease: Case Report and Literature Review.
    Yonezawa H, Hayashi K, Yamamoto N, Takeuchi A, Tada K, Miwa S, Igarashi K, Kimura H, Aoki Y, Morinaga S, Araki Y, Asano Y, Sakurakichi K, Ikeda H, Nojima T, Tsuchiya H.
    Calcif Tissue Int; 2021 Jun; 108(6):819-824. PubMed ID: 33555353
    [Abstract] [Full Text] [Related]

  • 6. Losartan as a Steroid-Sparing Adjunct in a Patient With Features of Refractory Camurati-Engelmann Disease.
    Agarwal K, Rajan R, Paul J, Cherian KE, Kapoor N, Paul TV.
    AACE Clin Case Rep; 2022 Jun; 8(2):54-57. PubMed ID: 35415233
    [Abstract] [Full Text] [Related]

  • 7. The first Korean case of Camurati-Engelmann disease (progressive diaphyseal dysplasia) confirmed by TGFB1 gene mutation analysis.
    Park SJ, Yoon CS, Park HW, Choi JR, Chung JS, Lee KA.
    J Korean Med Sci; 2009 Aug; 24(4):737-40. PubMed ID: 19654961
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Unveiling the uncommon: diagnostic journey of camurati-engelmann disease in a pediatric patient.
    Alkaya A, Yıldız AE, Bağlan E, Özdel S.
    Pediatr Rheumatol Online J; 2024 Oct 08; 22(1):89. PubMed ID: 39379987
    [Abstract] [Full Text] [Related]

  • 10. Camurati-Engelmann Disease.
    Van Hul W, Boudin E, Vanhoenacker FM, Mortier G.
    Calcif Tissue Int; 2019 May 08; 104(5):554-560. PubMed ID: 30721323
    [Abstract] [Full Text] [Related]

  • 11. Camurati-Engelmann Disease with Good Treatment Response to Losartan.
    Abdulla MC.
    Indian J Nucl Med; 2019 May 08; 34(3):223-225. PubMed ID: 31293304
    [Abstract] [Full Text] [Related]

  • 12. Camurati-Engelmann disease in conjunction with hypogonadism.
    Gupta S, Cheikh IE.
    Endocr Pract; 2005 May 08; 11(6):399-407. PubMed ID: 16638728
    [Abstract] [Full Text] [Related]

  • 13. Surgery Treatment of an Adult Patient with Camurati-Engelmann Disease: A Case Report.
    Saboya F, Medina A, Cadavid S, Fuentes R, Jiménez-Canizales CE.
    JBJS Case Connect; 2021 Aug 05; 11(3):. PubMed ID: 34351871
    [Abstract] [Full Text] [Related]

  • 14. Mild Camurati‑Engelamann disease presenting with exophthalmos as the first and only manifestation: A case report.
    Jiajue R, Wu B, Jiang Y, Wang O, Li M, Xing X, Xia W.
    Mol Med Rep; 2016 Sep 05; 14(3):2710-6. PubMed ID: 27484238
    [Abstract] [Full Text] [Related]

  • 15. Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment.
    Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van Maldergem L, Ralston S, Guañabens N, Migone N, Wientroub S, Divizia MT, Bergmann C, Bennett C, Simsek S, Melançon S, Cundy T, Van Hul W.
    J Med Genet; 2006 Jan 05; 43(1):1-11. PubMed ID: 15894597
    [Abstract] [Full Text] [Related]

  • 16. Camurati-Engelmann disease: contribution of bone scintigraphy to genetic counseling.
    Clybouw C, Desmyttere S, Bonduelle M, Piepsz A.
    Genet Couns; 1994 Jan 05; 5(2):195-8. PubMed ID: 7917133
    [Abstract] [Full Text] [Related]

  • 17. Positive effects of an angiotensin II type 1 receptor antagonist in Camurati-Engelmann disease: a single case observation.
    Simsek-Kiper PO, Dikoglu E, Campos-Xavier B, Utine GE, Bonafe L, Unger S, Boduroglu K, Superti-Furga A.
    Am J Med Genet A; 2014 Oct 05; 164A(10):2667-71. PubMed ID: 25099136
    [Abstract] [Full Text] [Related]

  • 18. A Case Report of a 44-Year-Old Woman With Camurati-Englemann Disease: A Case Report.
    Owhonda RA, Wells JE, Lloyd EW, Mumm S, Kimonis V.
    JBJS Case Connect; 2020 Oct 05; 10(3):e19.00400. PubMed ID: 32668141
    [Abstract] [Full Text] [Related]

  • 19. Improvement of Bone Health and Initiation of Puberty Development in Camurati-Engelmann Disease With Glucocorticoid and Losartan Treatment: A Case Report and Review of Literature.
    Cui L, Li Q, Guan W, Yu W, Li X, Xia W, Jiang Y.
    Front Endocrinol (Lausanne); 2022 Oct 05; 13():882144. PubMed ID: 35784539
    [Abstract] [Full Text] [Related]

  • 20. Camurati-Engelmann disease--a rare cause of bone pain.
    Mundra V, Taxel P.
    Conn Med; 2012 Jan 05; 76(1):33-7. PubMed ID: 22372177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.